D002443Chemicals & DrugsD02.065.589.099.249.190.190.155D02.886.665.074.190.190.155D03.633.100.300.249.190.190.155890.996002Ceftriaxoneprns:emailEncryptedemail addressFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.2422510.004102188research area of0.9496910.016474613subject area forBiochemistry and Molecular BiologyMicrobiology32643519Scardina T, Stach L, Sun S, Kociolek LK, Reuter C, Vogt M, Patel SJournal of pharmacy practiceDocumentation of Indications: Agreement Between Order Entry and Clinical Notes and Effect on Time to Antibiotic Administration. J Pharm Pract. 2022 Feb; 35(1):13-19.J Pharm Pract2020-07-09T00:00:002020Documentation of Indications: Agreement Between Order Entry and Clinical Notes and Effect on Time to Antibiotic Administration.30628967Wang Y, Pan T, Ma FR, Wang JJ, Zhang K, Pan WW, Zhang JH, Yi ZM, Ying YQChinese medical journalCeftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant. Chin Med J (Engl). 2019 Jan 05; 132(1):100-102.Chin Med J (Engl)2019-01-05T00:00:002019Ceftriaxone-induced immune hemolytic anemia in a case with large vestibular aqueduct syndrome after cochlear implant.https://openwetware.org/wiki/Pan_LabPan Lab sitehttps://voices.uchicago.edu/missiakaslab/Missiakas LabSimonParzen-JohnsonSimon Parzen-Johnson41.7886000000000087.598699999999994390Parzen-Johnson, SimonAssistant Professor37285212Naureckas Li C, Parzen-Johnson S, Jhaveri RJournal of the Pediatric Infectious Diseases SocietyBiliary Complications of Prolonged Ceftriaxone Use in Patients With Intracranial Infections. J Pediatric Infect Dis Soc. 2023 06 30; 12(6):379-380.J Pediatric Infect Dis Soc2023-06-30T00:00:002023Biliary Complications of Prolonged Ceftriaxone Use in Patients With Intracranial Infections.NeurologyPediatricsUniversity of ChicagoTaoPanw2NmG6AbOfnamXNnYUHhvWD+6g==Tao Pan41.78927490000000-87.601250000000001308Pan, TaoProfessorLarryKociolekLarry Kociolek41.78927490000000-87.601250000000001531Kociolek, LarryClinical AssociateKouroshRezaniaKourosh Rezania41.78927490000000-87.601250000000001791Rezania, KouroshProfessorDominiqueMissiakas029gGLIcGOf5hHlsaUXv9Gq0+s+oDominique Missiakas41.78927490000000-87.601250000000002010Missiakas, DominiqueProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Clinical AssociateClinical Associatetrue1Assistant ProfessorAssistant Professor24771634Zhao Y, Cudkowicz ME, Shefner JM, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Harmatz JS, Schoenfeld D, Greenblatt DJJournal of clinical pharmacologySystemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis. J Clin Pharmacol. 2014 Oct; 54(10):1180-7.J Clin Pharmacol2014-05-16T00:00:002014Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis.1010Pediatrics-Infectious Diseases23613806Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME, Northeast ALS ConsortiumPloS oneDesign and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013; 8(4):e61177.PLoS One2013-04-17T00:00:002013Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.